Crino L - Search Results

1

Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors.

Soria JC, Shepherd FA, Douillard JY, Wolf J, Giaccone G, Crino L, Cappuzzo F, Sharma S, Gross SH, Dimitrijevic S, Di Scala L, Gardner H, Nogova L, Papadimitrakopoulou V. Soria JC, et al. Among authors: crino l. Ann Oncol. 2009 Oct;20(10):1674-81. doi: 10.1093/annonc/mdp060. Epub 2009 Jun 23. Ann Oncol. 2009. PMID: 19549709 Free article.

2

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

Crinò L, Clerici M, Figoli F, Carlini P, Ceci G, Cortesi E, Carpi A, Santini A, Di Costanzo F, Boni C, et al. Crinò L, et al. Ann Oncol. 1995 Apr;6(4):347-53. doi: 10.1093/oxfordjournals.annonc.a059183. Ann Oncol. 1995. PMID: 7619749 Free article. Clinical Trial.

3

Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer.

Crinò L, Latini P, Meacci M, Corgna E, Maranzano E, Darwish S, Minotti V, Santucci A, Tonato M. Crinò L, et al. Ann Oncol. 1993 Dec;4(10):847-51. doi: 10.1093/oxfordjournals.annonc.a058391. Ann Oncol. 1993. PMID: 8117604 Clinical Trial.

4

Chemotherapy in advanced non-small-cell lung cancer. The experience of Italian Cooperative Groups.

Crinò L. Crinò L. Ann Oncol. 1995;6 Suppl 3:S45-7. doi: 10.1093/annonc/6.suppl_3.s45. Ann Oncol. 1995. PMID: 8616115 Free article.

5

A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification.

Crinò L, Corgna E, Porrozzi S, Palladino MA, Darwish S, Minotti V, Mosconi AM, Tonato M. Crinò L, et al. Ann Oncol. 1997 Jul;8(7):709-11. doi: 10.1023/a:1008277604261. Ann Oncol. 1997. PMID: 9296229 Free article. Clinical Trial.

6

Combined cisplatin and gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery.

Abratt RP, Sandler A, Crinò L, Steward WP, Shepherd FA, Green MR, Nguyen B, Peters GJ. Abratt RP, et al. Among authors: crino l. Semin Oncol. 1998 Aug;25(4 Suppl 9):35-43. Semin Oncol. 1998. PMID: 9728583

7

Medical treatment of brain metastases from solid tumours.

Cappuzzo F, Mazzoni F, Maestri A, Di Stefano A, Calandri C, Crino L. Cappuzzo F, et al. Among authors: crino l. Forum (Genova). 2000 Apr-Jun;10(2):137-48. Forum (Genova). 2000. PMID: 10875975 Review.

8

The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer.

Shepherd FA, Abratt R, Crino L, Green M, Sandler A, Steward W, Iglesias J, Anglin G. Shepherd FA, et al. Among authors: crino l. Lung Cancer. 2000 Nov;30(2):117-25. doi: 10.1016/s0169-5002(00)00135-5. Lung Cancer. 2000. PMID: 11086205

9

A three-week schedule of gemcitabine-cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: a phase II randomized trial.

Rinaldi M, Crinò L, Scagliotti GV, Mosconi AM, De Marinis F, Gridelli C, Selvaggi G, Della Giulia M, Darwish S, Porrozzi S, Novello S, Cipri A, Bartolucci R, Calandri C, Tonato M. Rinaldi M, et al. Among authors: crino l. Ann Oncol. 2000 Oct;11(10):1295-300. doi: 10.1023/a:1008334610955. Ann Oncol. 2000. PMID: 11106119 Free article. Clinical Trial.

10

[Role of gemcitabine in the treatment of advanced non-small cell lung cancer: review of the main phase II and phase III trials].

Crino L, Cappuzzo F. Crino L, et al. Anticancer Drugs. 2001 Jul;12 Suppl 3:S9-13. Anticancer Drugs. 2001. PMID: 11556252 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

343 results

Search Page